STOCK TITAN

Laurence Lytton and Foundation Hold 9.99% in IN8BIO (NASDAQ: INAB)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

IN8BIO, Inc. reports that Laurence W. Lytton and the Lytton-Kambara Foundation each beneficially own 9.99% of Common Stock, consisting of 984,031 shares reported for each holder.

The filing states that the reported holdings "consist of 900,000 shares of Common Stock and warrants to purchase 1,092,753 shares of Common Stock, subject to a 9.99% beneficial ownership limitation," and that the percentage was calculated based on 9,766,132 shares outstanding as of January 12, 2026, per a prospectus dated January 28, 2026.

Positive

  • None.

Negative

  • None.

Insights

Holders report large, capped stakes via shared power and warrants.

The filing shows shared voting and dispositive power of 984,031 shares for both Laurence W. Lytton and the Lytton-Kambara Foundation, each equal to 9.99% of the class as calculated on January 12, 2026.

Reported holdings "consist of 900,000 shares and warrants to purchase 1,092,753 shares," with a beneficial ownership limitation of 9.99%. Timing and exercise mechanics for the warrants are not detailed in the excerpt; subsequent filings may clarify potential conversion timing and dilution.






12/22/2025

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The shares of the Common Stock reported herein consist of 900,000 shares of Common Stock and warrants to purchase 1,092,753 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. Percentage calculated based on 9,766,132 shares of Common Stock outstanding on January 12, 2026, as reported in the Prospectus dated January 28, 2026 filed by the Issuer on January 30, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The shares of the Common Stock reported herein consist of 900,000 shares of Common Stock and warrants to purchase 1,092,753 shares of Common Stock, subject to a 9.99% beneficial ownership limitation. Percentage calculated based on 9,766,132 shares of Common Stock outstanding on January 12, 2026, as reported in the Prospectus dated January 28, 2026 filed by the Issuer on January 30, 2026.


SCHEDULE 13G



LYTTON LAURENCE W
Signature:/s/ Laurence W Lytton
Name/Title:Reporting Person
Date:03/02/2026
LYTTON-KAMBARA FOUNDATION
Signature:/s/ Laurence W Lytton
Name/Title:President
Date:03/02/2026
Exhibit Information

EXHIBIT 99.1 - AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G

FAQ

What stake does Laurence W. Lytton report in IN8BIO (INAB)?

Laurence W. Lytton reports beneficial ownership of 984,031 shares, equal to 9.99% of the class, calculated on January 12, 2026 based on 9,766,132 shares outstanding.

What does the Lytton-Kambara Foundation own in IN8BIO (INAB)?

The Lytton-Kambara Foundation reports beneficial ownership of 984,031 shares, equal to 9.99% of the class, using the same January 12, 2026 outstanding share base of 9,766,132 shares.

Do the reported holdings include warrants or other instruments?

Yes. The filing states reported holdings "consist of 900,000 shares and warrants to purchase 1,092,753 shares," and are subject to a 9.99% beneficial ownership limitation.

How is the 9.99% percentage calculated in the filing?

The 9.99% figure is calculated using 9,766,132 shares outstanding as of January 12, 2026, cited from a prospectus dated January 28, 2026 filed on January 30, 2026.

Who has voting and dispositive power over the reported shares?

The filing reports 0 sole voting/dispositive power and 984,031 shared voting and dispositive power for both Laurence W. Lytton and the Lytton-Kambara Foundation.
In8Bio, Inc.

NASDAQ:INAB

INAB Rankings

INAB Latest News

INAB Latest SEC Filings

INAB Stock Data

16.60M
8.63M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
NEW YORK